Resultados de la búsqueda 241-250 of 11255 for anti-TNF drugs
The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...
AskMayoExpert. COVID:19 Drug regimens and other treatment options. Mayo Clinic. 2023. Emergency use authorization. U.S. Food and Drug Administration. https:// ...
Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now. Rochester, Minn. REVOLUTION will be a US multicenter observational registry ...
Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Prospective Use Of Philips ISuite For Interventional ...
Testing The Addition Of A New Drug, Venetoclax, To The Usual Treatment (Ibrutinib And Rituximab) For Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma.
... therapy. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?